Fluidigm develops, manufactures, and markets proprietary integrated fluidic circuit (IFC) systems that significantly improve productivity for life science applications such as gene expression profiling, high-throughput SNP genotyping, singe cell/stem cell analysis, digital PCR, LOH and CNV analysis, mutation detection, and next gen sequencing. Fluidigm?? IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in nanoliter volumes. These ??ntegrated circuits for biology??miniaturize and integrate liquid handling components on a single microfabricated device. Fluidigm?? IFC systems, consisting of instrumentation, software and single-use IFCs, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems. Fluidigm products have not been cleared or approved by the U.S. Food and Drug Administration for use as a diagnostic and are only available for research use.